Viewing Study NCT03523858

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2025-12-31 @ 8:19 PM
Study NCT ID: NCT03523858
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-04
First Post: 2018-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
Sponsor: Hoffmann-La Roche
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Progressive Multiple Sclerosis (PMS) View
Keywords: